Sale!

TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the TGFB3 gene associated with ARVC Type 1. This comprehensive test utilizes Next-Generation Sequencing technology to detect specific genetic variants that can lead to progressive heart muscle disease, abnormal heart rhythms, and increased risk of sudden cardiac death. The test is particularly valuable for individuals with family history of cardiomyopathy, unexplained cardiac symptoms, or those seeking proactive heart health assessment. Results provide crucial information for early intervention, personalized treatment planning, and family screening recommendations. The test costs $500 USD and offers life-saving insights into inherited cardiovascular conditions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test

Comprehensive Genetic Screening for Inherited Heart Conditions

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic medicine. This advanced diagnostic tool specifically targets mutations in the TGFB3 gene, which plays a critical role in the development and maintenance of healthy heart muscle tissue. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Type 1 is a serious inherited condition characterized by progressive replacement of heart muscle with fatty and fibrous tissue, leading to dangerous heart rhythm disturbances and potential sudden cardiac death.

What This Test Measures and Detects

Our comprehensive NGS-based genetic analysis examines the entire TGFB3 gene sequence to identify:

  • Pathogenic variants associated with ARVC Type 1 development
  • Missense mutations affecting protein function
  • Frameshift mutations disrupting gene expression
  • Nonsense mutations leading to premature protein termination
  • Splice site variants affecting RNA processing
  • Copy number variations impacting gene dosage

The test utilizes state-of-the-art Next-Generation Sequencing technology, providing unparalleled accuracy in detecting even rare genetic variants that conventional methods might miss. This comprehensive approach ensures thorough assessment of genetic risk factors for this life-threatening cardiac condition.

Who Should Consider This Genetic Screening

This test is particularly recommended for individuals experiencing:

  • Unexplained palpitations or irregular heartbeats
  • Family history of sudden cardiac death or cardiomyopathy
  • Abnormal electrocardiogram (ECG) findings suggestive of ARVC
  • Cardiac symptoms during physical exertion
  • Diagnosed relatives with TGFB3-related cardiomyopathy
  • Young individuals with syncope or near-fainting episodes
  • Athletes with exercise-induced cardiac symptoms

Significant Benefits of Genetic Testing

Undergoing TGFB3 genetic testing provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptoms develop
  • Personalized Treatment Planning: Guide medication choices and lifestyle modifications
  • Family Screening Opportunities: Identify at-risk relatives for preventive care
  • Sports Participation Guidance: Make informed decisions about athletic activities
  • Psychological Relief: Reduce uncertainty about inherited cardiac conditions
  • Reproductive Planning: Understand inheritance patterns for family planning

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret results effectively:

  • Positive Result: Indicates presence of TGFB3 mutation; requires cardiology follow-up and family screening
  • Negative Result: No detected mutation; significantly reduces but doesn’t eliminate ARVC risk
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Important for reproductive planning and family risk assessment

All results include detailed explanations and recommendations for next steps, including appropriate medical specialists and monitoring protocols.

Test Pricing and Availability

Test Name Discount Price Regular Price
TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and cardiovascular specialists ensures comprehensive care regardless of your location.

Take Control of Your Heart Health Today

Don’t wait to understand your genetic risk for inherited heart conditions. Early detection through TGFB3 genetic testing can be life-saving. Our team of genetic specialists and cardiologists are ready to guide you through the testing process and provide personalized recommendations based on your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 NGS Genetic DNA Test. Take the first step toward proactive heart health management and peace of mind for you and your family.